Mutations in FKBP10 cause recessive osteogenesis imperfecta and bruck syndrome

Abstract

Osteogenesis imperfecta (OI) is a genetic disorder of connective tissue characterized by bone fragility and alteration in synthesis and posttranslational modification of type I collagen. Autosomal dominant OI is caused by mutations in the genes (COL1A1 or COL1A2) encoding the chains of type I collagen. Bruck syndrome is a recessive disorder featuring congenital contractures in addition to bone fragility; Bruck syndrome type 2 is caused by mutations in PLOD2 encoding collagen lysyl hydroxylase, whereas Bruck syndrome type 1 has been mapped to chromosome 17, with evidence suggesting region 17p12, but the gene has remained elusive so far. Recently, the molecular spectrum of OI has been expanded with the description of the basis of a unique posttranslational modification of type I procollagen, that is, 3-prolyl-hydroxylation. Three proteins, cartilage-associated protein (CRTAP), prolyl-3-hydroxylase-1 (P3H1, encoded by the LEPRE1 gene), and the prolyl cis-trans isomerase cyclophilin-B (PPIB), form a complex that is required for fibrillar collagen 3-prolyl-hydroxylation, and mutations in each gene have been shown to cause recessive forms of OI. Since then, an additional putative collagen chaperone complex, composed of FKBP10 (also known as FKBP65) and SERPINH1 (also known as HSP47), also has been shown to be mutated in recessive OI. Here we describe five families with OI-like bone fragility in association with congenital contractures who all had FKBP10 mutations. Therefore, we conclude that FKBP10 mutations are a cause of recessive osteogenesis imperfecta and Bruck syndrome, possibly Bruck syndrome Type 1 since the location on chromosome 17 has not been definitely localized. © 2011 American Society for Bone and Mineral Research.

Shown for reading. Its publisher allows quoting it, not republishing it.

References 24

1. 1.

   Morello R, Bertin TK, Chen Y, et al. CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta. Cell. 2006;127:291-304.

   Not in our library10.1016/j.cell.2006.08.039

2. 2.

   Marini JC, Cabral WA, Barnes AM. Null mutations in LEPRE1 and CRTAP cause severe recessive osteogenesis imperfecta. Cell Tissue Res. 2010;339:59-70.

   Not in our library10.1007/s00441-009-0872-0

3. 3.

   van Dijk FS, Nesbitt IM, Zwikstra EH, et al. PPIB mutations cause severe osteogenesis imperfecta. Am J Hum Genet. 2009;85:521-527.

   Not in our library10.1016/j.ajhg.2009.09.001

4. 4.

   Baldridge D, Schwarze U, Morello R, et al. CRTAP and LEPRE1 mutations in recessive osteogenesis imperfecta. Hum Mutat. 2008;29:1435-1442.

   Not in our library10.1002/humu.20799

5. 5.

   Christiansen HE, Schwarze U, Pyott SM, et al. Homozygosity for a missense mutation in SERPINH1, which encodes the collagen chaperone protein HSP47, results in severe recessive osteogenesis imperfecta. Am J Hum Genet. 2010;86:389-398.

   Not in our library10.1016/j.ajhg.2010.01.034

6. 6.

   Alanay Y, Avaygan H, Camacho N, et al. Mutations in the gene encoding the RER chaperone FKBP65 produce autosomal recessive osteogenesis imperfecta. Am J Hum Genet. 2010;86:551-559.

   Not in our library10.1016/j.ajhg.2010.02.022

7. 7.
   Defective collagen crosslinking in bone, but not in ligament or cartilage, in Bruck syndrome: Indications for a bone-specific telopeptide lysyl hydroxylase on chromosome 17 · 1999

   Not checked
8. 8.

   Eyre DR, Paz MA, Gallop PM. Cross-linking in collagen and elastin. Annu Rev Biochem. 1984;53:717-748.

   Not in our library10.1146/annurev.bi.53.070184.003441

9. 9.

   Ronziere MC, Berthet-Colominas C, Herbage D. Low-angle X-ray diffraction analysis of the collagen-proteoglycan interactions in articular cartilage. Biochim Biophys Acta. 1985;842:170-175.

   Not in our library

10. 10.

    Reiser K, McCormick RJ, Rucker RB. Enzymatic and nonenzymatic cross-linking of collagen and elastin. FASEB J. 1992;6:2439-2449.

    Not in our library10.1096/fasebj.6.7.1348714

11. 11.

    Robins SP. Analysis of the crosslinking components in collagen and elastin. Methods Biochem Anal. 1982;28:329-379.

    Not in our library10.1002/9780470110485.ch8

12. 12.

    Eyre DR, Koob TJ, Van Ness KP. Quantitation of hydroxypyridinium crosslinks in collagen by high-performance liquid chromatography. Anal Biochem. 1984;137:380-388.

    Not in our library10.1016/0003-2697(84)90101-5

13. 13.

    Breslau-Siderius EJ, Engelbert RH, Pals G, van der Sluijs JA. Bruck syndrome: a rare combination of bone fragility and multiple congenital joint contractures. J Pediatr Orthop B. 1998;7:35-38.

    Not in our library

14. 14.

    van der Slot AJ, Zuurmond AM, Bardoel AF, et al. Identification of PLOD2 as telopeptide lysyl hydroxylase, an important enzyme in fibrosis. J Biol Chem. 2003;278:40967-40972.

    Not in our library10.1074/jbc.m307380200

15. 15.

    Davis EC, Broekelmann TJ, Ozawa Y, Mecham RP. Identification of tropoelastin as a ligand for the 65-kD FK506-binding protein, FKBP65, in the secretory pathway. J Cell Biol. 1998;140:295-303.

    Not in our library10.1083/jcb.140.2.295

16. 16.

    Zeng B, MacDonald JR, Bann JG, et al. Chicken FK506-binding protein, FKBP65, a member of the FKBP family of peptidylprolyl cis-trans isomerases, is only partially inhibited by FK506. Biochem J. 1998;330:109-114.

    Not in our library10.1042/bj3300109

17. 17.

    Ishikawa Y, Vranka J, Wirz J, Nagata K, Bachinger HP. The rough endoplasmic reticulum-resident FK506-binding protein FKBP65 is a molecular chaperone that interacts with collagens. J Biol Chem. 2008;283:31584-31590.

    Not in our library10.1074/jbc.m802535200

18. 18.

    Ishida Y, Kubota H, Yamamoto A, Kitamura A, Bachinger HP, Nagata K. Type I collagen in Hsp47-null cells is aggregated in endoplasmic reticulum and deficient in N-propeptide processing and fibrillogenesis. Mol Biol Cell. 2006;17:2346-2355.

    Not in our library10.1091/mbc.e05-11-1065

19. 19.

    Drogemuller C, Becker D, Brunner A, et al. A missense mutation in the SERPINH1 gene in Dachshunds with osteogenesis imperfecta. PLoS Genet. 2009;5:e1000579.

    Not in our library10.1371/journal.pgen.1000579

20. 20.

    Mokete L, Robertson A, Viljoen D, Beighton P. Bruck syndrome: congenital joint contractures with bone fragility. J Orthop Sci. 2005;10:641-646.

    Not in our library10.1007/s00776-005-0958-9

21. 21.

    Viljoen D, Versfeld G, Beighton P. Osteogenesis imperfecta with congenital joint contractures (Bruck syndrome). Clin Genet. 1989;36:122-126.

    Not in our library10.1111/j.1399-0004.1989.tb03174.x

22. 22.

    Byers PH, Cole WG, Royce PM, Steinmann BU. Osteogenesis Imperfecta. Connective tissue and it heritable disorders: molecular, genetic, and medical aspects. 2002;285-430.

    Not in our library

23. 23.

    Marini JC, Forlino A, Cabral WA, et al. Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Hum Mut. 2006;28:209-221.

    Not in our library10.1002/humu.20429

24. 24.

    Ha-Vinh R, Alanay Y, et al. Phenotypic and molecular characterization of Bruck syndrome (osteogenesis imperfecta with contractures of the large joints) caused by a recessive mutation in PLOD2. Am J Med Genet A. 2004;131:115-120.

    Not in our library10.1002/ajmg.a.30231

Cited by papers we hold 3

• The missing link between genetic association and regulatory function · 2022
  No notice
• From Structure to Phenotype: Impact of Collagen Alterations on Human Health · 2018
  No notice
• Mutations in SERPINF1 cause osteogenesis imperfecta type VI · 2011
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.